Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotal registred%No. of excluded casesIncluded cases
HVDCODCONo. follow-upOthersTotal%No.%
China - Hong Kong SAR 1996-2001344190.70.51712172356.8320693.2
China - Qidong 1992-20005567.30.000000.055100.0
China - Shangai 1992-199564163.20.211020.363999.7
China - Tianjin 1991-199942359.60.000000.0423100.0
India - Karunagappally 1991-19973467.60.002025.93294.1
India - Mumbai 1992-1994162271.69.1148831599.8146390.2
Singapore 1993-199779695.10.54391445.575294.5
Republic of Korea - Busan 1996-200145481.14.82220245.343094.7
Republic of Korea - Incheon 1997-200130983.88.72700278.728291.3
Republic of Korea - Seoul 1993-1997105181.34.7495401039.894890.2
Thailand - Chiang Mai 1993-199714892.60.003924127.710772.3
Thailand - Lampang 1990-200017688.12.850052.817197.2
Thailand - Songkhla 1990-199917490.80.612903017.214482.8
Uganda - Kampala 1993-199721376.50.0040195927.715472.3
Zimbabwe - Harare 1993-19977357.59.6720912.36487.7



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period